United States v. Sydney Navarro , 582 F. App'x 510 ( 2014 )


Menu:
  •      Case: 14-10022      Document: 00512788681         Page: 1    Date Filed: 10/01/2014
    IN THE UNITED STATES COURT OF APPEALS
    FOR THE FIFTH CIRCUIT
    No. 14-10022
    Summary Calendar
    United States Court of Appeals
    Fifth Circuit
    FILED
    October 1, 2014
    UNITED STATES OF AMERICA,
    Lyle W. Cayce
    Clerk
    Plaintiff-Appellee
    v.
    SYDNEY MELISSA NAVARRO,
    Defendant-Appellant
    Appeal from the United States District Court
    for the Northern District of Texas
    USDC No. 4:13-CR-100-7
    Before JONES, BENAVIDES, and GRAVES, Circuit Judges.
    PER CURIAM: *
    Sydney Melissa Navarro pleaded guilty to conspiracy to possess with
    intent to distribute 50 grams or more of a mixture or substance containing a
    detectable amount of methamphetamine and was sentenced to a 324-month
    term of imprisonment. Navarro now appeals her sentence. We review the
    district court’s application of the Sentencing Guidelines de novo, and its factual
    * Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not
    be published and is not precedent except under the limited circumstances set forth in 5TH
    CIR. R. 47.5.4.
    Case: 14-10022     Document: 00512788681     Page: 2     Date Filed: 10/01/2014
    No. 14-10022
    findings are reviewed for clear error. United States v. Villanueva, 
    408 F.3d 193
    , 202-03 & n.9 (5th Cir. 2005).
    Navarro’s first issue concerns the calculation of her base offense level
    (BOL) under U.S.S.G. § 2D1.1(c). She does not dispute the finding that she
    was responsible for 1,786.05 grams of a mixture or substance containing
    methamphetamine, a quantity that would result in a BOL of 34. § 2D1.1(c)(3).
    Finding that a quantity of drugs seized from Navarro’s sole supplier had an
    average purity rate of 92.2%, however, the district court used that purity rate
    to determine that the drug mixture attributable to Navarro contained more
    than 1.5 kilograms of actual methamphetamine and to assign Navarro a BOL
    of 38. § 2D1.1(c)(1). Given the evidence that the drug mixture attributable to
    Navarro and the drug mixture that was analyzed for purity all came from the
    same, sole source, a finding that the drugs attributable to Navarro also had an
    average purity rate of 92.2% is plausible and, thus, not clearly erroneous. See
    United States v. Rodriguez, 
    666 F.3d 944
    , 947 (5th Cir. 2012). Additionally,
    nothing in the record suggests that the drugs attributable to Navarro had an
    average purity rate of less than 80%. Even assuming a purity rate of only 80%,
    the district court did not err in applying a BOL of 38 in this case.            See
    Rodriguez, 
    666 F.3d at 947
    ; United States v. Sherrod, 
    964 F.2d 1501
    , 1508 (5th
    Cir. 1992); § 2D1.1(c)(1); § 2D1.1(c)(1), Notes (B) & (C).
    We turn next to Navarro’s argument that the district court erred in
    applying a two-level enhancement under § 2D1.1(b)(12) for maintaining a
    premises for the purpose of manufacturing or distributing a controlled
    substance. Testimony from a law enforcement officer at sentencing and the
    unrebutted facts in the PSR and its addenda support the district court’s finding
    that Navarro and her on-and-off boyfriend moved from hotel to hotel, selling
    methamphetamine from the rooms in which they stayed. It also supports the
    2
    Case: 14-10022      Document: 00512788681   Page: 3   Date Filed: 10/01/2014
    No. 14-10022
    finding that Navarro used a residence in Fort Worth, Texas, to run her drug-
    trafficking business.    Navarro offers no legal support for her conclusional
    argument that a premises must be specifically identified as a prerequisite to
    its use for the application of a § 2D1.1(b)(12) enhancement. Navarro has not
    shown that the district court’s factual findings were clearly erroneous or that
    it erred in applying § 2D1.1(b)(12) in this case. See Alaniz, 726 F.3d at 618;
    § 2D1.1(b)(12) & comment. (n.17).
    AFFIRMED.
    3
    

Document Info

Docket Number: 14-10022

Citation Numbers: 582 F. App'x 510

Filed Date: 10/1/2014

Precedential Status: Non-Precedential

Modified Date: 1/13/2023